Evidence map›Paper›PMID 42395267›Full record

ArticleOncology letters2026

Methylation of the

Samantha Rebeca de la Torre-Guzmán, Andrea Marlene García Muro, Brenda Pelayo-Chávez, Carolina Vázquez-Gastélum, Martha Patricia Gallegos-Arreola, Ernesto Soto-Reyes, Sergio Osvaldo Meza-Chavolla, Josefina Yoaly Sánchez-López

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Samantha Rebeca de la Torre-GuzmánGenetics Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, Jalisco 44340, Mexico.
Andrea Marlene García MuroGenetics Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, Jalisco 44340, Mexico.
Brenda Pelayo-ChávezGenetics Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, Jalisco 44340, Mexico.
Carolina Vázquez-GastélumGenetics Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, Jalisco 44340, Mexico.
Martha Patricia Gallegos-ArreolaGenetics Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, Jalisco 44340, Mexico.
Ernesto Soto-ReyesDepartment of Natural Sciences, Autonomous Metropolitan University-Cuajimalpa (UAM-C), Mexico City 05348, Mexico.
Sergio Osvaldo Meza-ChavollaBreast Detection and Diagnosis Unit, Mexican Social Security Institute, Guadalajara, Jalisco 44300, Mexico.
Josefina Yoaly Sánchez-LópezGenetics Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, Jalisco 44340, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is the main cause of cancer-related mortality in women and is influenced by genetic, environmental and lifestyle factors. The inactivation of tumor suppressor genes, such as bone morphogenetic protein 6 (

Indexed as

benign diseasebreast cancerepigeneticsgeneticsmethylationprognosis

Identifiers

PMID42395267
PMCPMC13324278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.